Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 27 | 2023 | 754 | 5.100 |
Why?
|
| Hernia, Inguinal | 14 | 2022 | 67 | 3.360 |
Why?
|
| Herniorrhaphy | 14 | 2023 | 79 | 2.890 |
Why?
|
| Peritoneal Dialysis | 4 | 2023 | 32 | 2.600 |
Why?
|
| Kidney Failure, Chronic | 5 | 2023 | 509 | 1.780 |
Why?
|
| Simulation Training | 7 | 2022 | 88 | 1.680 |
Why?
|
| Catheters, Indwelling | 4 | 2023 | 110 | 1.640 |
Why?
|
| Catheterization | 4 | 2023 | 232 | 1.360 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 3 | 2015 | 10 | 1.320 |
Why?
|
| Hernia, Abdominal | 3 | 2021 | 14 | 1.140 |
Why?
|
| Surgical Mesh | 8 | 2023 | 116 | 1.060 |
Why?
|
| Peritoneum | 3 | 2023 | 57 | 1.000 |
Why?
|
| Edema | 2 | 2015 | 71 | 0.990 |
Why?
|
| Curriculum | 8 | 2022 | 539 | 0.940 |
Why?
|
| Abdominal Wall | 2 | 2020 | 30 | 0.870 |
Why?
|
| Gastroesophageal Reflux | 5 | 2022 | 117 | 0.820 |
Why?
|
| Quality of Life | 14 | 2022 | 1585 | 0.800 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2022 | 50 | 0.750 |
Why?
|
| Internship and Residency | 5 | 2022 | 1004 | 0.740 |
Why?
|
| Robotic Surgical Procedures | 2 | 2022 | 267 | 0.730 |
Why?
|
| Rectus Abdominis | 2 | 2017 | 37 | 0.710 |
Why?
|
| Obesity, Morbid | 7 | 2022 | 225 | 0.650 |
Why?
|
| Treatment Outcome | 23 | 2023 | 7993 | 0.630 |
Why?
|
| Bariatric Surgery | 5 | 2022 | 194 | 0.620 |
Why?
|
| Surgeons | 4 | 2022 | 238 | 0.620 |
Why?
|
| Fundoplication | 7 | 2022 | 72 | 0.590 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 64 | 0.580 |
Why?
|
| Hernia, Hiatal | 3 | 2023 | 30 | 0.580 |
Why?
|
| Pyloromyotomy | 3 | 2021 | 11 | 0.570 |
Why?
|
| Omentum | 1 | 2016 | 71 | 0.560 |
Why?
|
| Myotomy | 3 | 2021 | 25 | 0.560 |
Why?
|
| Genitalia, Male | 1 | 2015 | 24 | 0.550 |
Why?
|
| Genitalia, Female | 1 | 2015 | 25 | 0.550 |
Why?
|
| Genitalia | 1 | 2015 | 21 | 0.550 |
Why?
|
| Retrospective Studies | 23 | 2023 | 8489 | 0.520 |
Why?
|
| Esophageal Achalasia | 3 | 2020 | 57 | 0.520 |
Why?
|
| Clinical Competence | 11 | 2022 | 751 | 0.520 |
Why?
|
| Humans | 60 | 2023 | 86644 | 0.520 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2020 | 38 | 0.500 |
Why?
|
| Scrotum | 1 | 2013 | 17 | 0.470 |
Why?
|
| Obesity | 2 | 2017 | 963 | 0.460 |
Why?
|
| Gastric Bypass | 3 | 2022 | 110 | 0.440 |
Why?
|
| Male | 33 | 2022 | 40966 | 0.420 |
Why?
|
| Aged | 19 | 2020 | 18415 | 0.410 |
Why?
|
| Recurrence | 5 | 2021 | 1139 | 0.410 |
Why?
|
| Esophageal Motility Disorders | 2 | 2022 | 12 | 0.410 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 115 | 0.400 |
Why?
|
| Pain, Postoperative | 5 | 2021 | 240 | 0.390 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 17 | 0.380 |
Why?
|
| Adult | 21 | 2023 | 25648 | 0.370 |
Why?
|
| Middle Aged | 24 | 2021 | 25028 | 0.360 |
Why?
|
| Female | 29 | 2022 | 44533 | 0.350 |
Why?
|
| Foreign Bodies | 2 | 2022 | 63 | 0.320 |
Why?
|
| Reoperation | 3 | 2021 | 597 | 0.310 |
Why?
|
| Stomach | 3 | 2016 | 108 | 0.300 |
Why?
|
| Catheterization, Peripheral | 1 | 2007 | 58 | 0.290 |
Why?
|
| Suture Techniques | 3 | 2016 | 135 | 0.290 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2021 | 32 | 0.280 |
Why?
|
| Incisional Hernia | 3 | 2021 | 17 | 0.280 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2207 | 0.270 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 3640 | 0.270 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2022 | 153 | 0.240 |
Why?
|
| Barrett Esophagus | 2 | 2015 | 93 | 0.240 |
Why?
|
| Laparotomy | 3 | 2019 | 59 | 0.240 |
Why?
|
| Physicians | 2 | 2021 | 673 | 0.230 |
Why?
|
| Virtual Reality | 1 | 2022 | 21 | 0.210 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 12 | 0.210 |
Why?
|
| Weight Loss | 3 | 2022 | 229 | 0.200 |
Why?
|
| Gastroparesis | 1 | 2021 | 14 | 0.200 |
Why?
|
| Safety | 1 | 2021 | 152 | 0.200 |
Why?
|
| Biological Products | 1 | 2023 | 143 | 0.200 |
Why?
|
| Esophagoplasty | 1 | 2020 | 10 | 0.190 |
Why?
|
| Computer Simulation | 5 | 2022 | 1078 | 0.190 |
Why?
|
| Insufflation | 1 | 2020 | 10 | 0.190 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 10 | 0.190 |
Why?
|
| Electric Impedance | 4 | 2021 | 104 | 0.190 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 185 | 0.190 |
Why?
|
| Cholecystitis | 1 | 2020 | 15 | 0.180 |
Why?
|
| Cholelithiasis | 1 | 2020 | 34 | 0.180 |
Why?
|
| Cholecystectomy | 1 | 2020 | 18 | 0.180 |
Why?
|
| Diverticulitis | 1 | 2019 | 9 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 120 | 0.180 |
Why?
|
| Jejunum | 2 | 2016 | 79 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2601 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2020 | 278 | 0.170 |
Why?
|
| Hernia, Ventral | 2 | 2017 | 24 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2019 | 31 | 0.170 |
Why?
|
| Teaching | 1 | 2020 | 147 | 0.170 |
Why?
|
| Perception | 1 | 2020 | 168 | 0.170 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 35 | 0.170 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 104 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2020 | 145 | 0.160 |
Why?
|
| Common Bile Duct | 1 | 2017 | 19 | 0.150 |
Why?
|
| Self-Assessment | 1 | 2017 | 47 | 0.150 |
Why?
|
| Acute Disease | 2 | 2019 | 826 | 0.150 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 12 | 0.150 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 88 | 0.150 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 41 | 0.150 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 35 | 0.150 |
Why?
|
| Societies, Medical | 1 | 2021 | 572 | 0.150 |
Why?
|
| Self Concept | 1 | 2017 | 133 | 0.150 |
Why?
|
| Referral and Consultation | 1 | 2020 | 328 | 0.150 |
Why?
|
| Dexamethasone | 1 | 2018 | 326 | 0.150 |
Why?
|
| Patient Safety | 1 | 2019 | 212 | 0.150 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 41 | 0.150 |
Why?
|
| Pain Measurement | 3 | 2020 | 321 | 0.140 |
Why?
|
| Equipment Safety | 1 | 2016 | 31 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 469 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2022 | 4214 | 0.140 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 13 | 0.140 |
Why?
|
| Equipment Failure | 1 | 2016 | 119 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2016 | 194 | 0.140 |
Why?
|
| Prostatectomy | 1 | 2019 | 471 | 0.140 |
Why?
|
| Esophagoscopy | 3 | 2020 | 87 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2019 | 2767 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2019 | 2261 | 0.130 |
Why?
|
| Gastroenterology | 1 | 2017 | 134 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2017 | 751 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 508 | 0.130 |
Why?
|
| Child | 2 | 2023 | 6927 | 0.130 |
Why?
|
| Time Factors | 3 | 2021 | 5210 | 0.130 |
Why?
|
| Contraindications | 1 | 2014 | 72 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 636 | 0.130 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 53 | 0.120 |
Why?
|
| Endoscopy | 3 | 2022 | 332 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 369 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2015 | 695 | 0.110 |
Why?
|
| Databases, Factual | 3 | 2021 | 814 | 0.110 |
Why?
|
| Esophagogastric Junction | 2 | 2021 | 34 | 0.100 |
Why?
|
| Swine | 2 | 2022 | 555 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6509 | 0.090 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 166 | 0.090 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 116 | 0.090 |
Why?
|
| United States | 2 | 2021 | 6672 | 0.090 |
Why?
|
| Operating Rooms | 2 | 2022 | 126 | 0.080 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 2501 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2019 | 272 | 0.070 |
Why?
|
| Abdomen | 1 | 2007 | 122 | 0.070 |
Why?
|
| Equipment Design | 1 | 2007 | 406 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2007 | 137 | 0.070 |
Why?
|
| Weight Gain | 2 | 2016 | 123 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2020 | 770 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3362 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2020 | 397 | 0.060 |
Why?
|
| Patient Selection | 3 | 2019 | 685 | 0.060 |
Why?
|
| Manometry | 1 | 2022 | 43 | 0.060 |
Why?
|
| Vitamin D | 2 | 2015 | 261 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 3679 | 0.050 |
Why?
|
| Bile Ducts | 1 | 2021 | 59 | 0.050 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 321 | 0.050 |
Why?
|
| Splenectomy | 1 | 2021 | 82 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2022 | 68 | 0.050 |
Why?
|
| Hernia | 1 | 2021 | 23 | 0.050 |
Why?
|
| Pylorus | 1 | 2021 | 14 | 0.050 |
Why?
|
| Gastric Emptying | 1 | 2021 | 23 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 164 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 65 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2022 | 185 | 0.050 |
Why?
|
| Spleen | 1 | 2021 | 430 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2020 | 65 | 0.050 |
Why?
|
| Publishing | 1 | 2021 | 90 | 0.050 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 229 | 0.050 |
Why?
|
| Esophagus | 1 | 2020 | 102 | 0.050 |
Why?
|
| Disease Progression | 2 | 2015 | 1531 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2022 | 246 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 14 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 162 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 204 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 161 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2020 | 221 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 45 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 377 | 0.040 |
Why?
|
| Urinary Retention | 1 | 2018 | 40 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 153 | 0.040 |
Why?
|
| Operative Time | 1 | 2019 | 127 | 0.040 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 84 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 327 | 0.040 |
Why?
|
| General Surgery | 1 | 2020 | 229 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 14 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2021 | 428 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2020 | 300 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1169 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 860 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 859 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 54 | 0.040 |
Why?
|
| Atrophy | 1 | 2017 | 117 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2016 | 22 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2380 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 999 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2020 | 339 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2018 | 352 | 0.040 |
Why?
|
| Granuloma | 1 | 1996 | 65 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 105 | 0.030 |
Why?
|
| Video Recording | 1 | 2016 | 190 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 303 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 31 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 849 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 261 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2014 | 7 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 297 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 237 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 360 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 228 | 0.030 |
Why?
|
| Risk Factors | 2 | 2015 | 5417 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 45 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 1996 | 196 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1801 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1621 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 231 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 462 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 26582 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 455 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 427 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 329 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 1186 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1054 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1577 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 429 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 2262 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 1239 | 0.010 |
Why?
|